Crescent Capital BDC, Inc. (NASDAQ:CCAP) Shares Sold by Kovitz Investment Group Partners LLC

Kovitz Investment Group Partners LLC trimmed its position in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 32.7% during the fourth quarter, Holdings Channel reports. The firm owned 177,345 shares of the company’s stock after selling 86,326 shares during the quarter. Kovitz Investment Group Partners LLC’s holdings in Crescent Capital BDC were worth $3,409,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Montag A & Associates Inc. purchased a new position in Crescent Capital BDC in the fourth quarter valued at $35,000. C M Bidwell & Associates Ltd. acquired a new position in Crescent Capital BDC in the 4th quarter valued at about $39,000. Generation Capital Management LLC purchased a new stake in shares of Crescent Capital BDC during the fourth quarter worth approximately $192,000. Dynamic Technology Lab Private Ltd purchased a new position in Crescent Capital BDC during the 4th quarter worth $218,000. Finally, NewEdge Advisors LLC raised its holdings in Crescent Capital BDC by 4,308.4% during the fourth quarter. NewEdge Advisors LLC now owns 12,079 shares of the company’s stock worth $232,000 after purchasing an additional 11,805 shares in the last quarter. 49.46% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Wells Fargo & Company decreased their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods lowered their price target on shares of Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating for the company in a report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Crescent Capital BDC presently has an average rating of “Moderate Buy” and an average target price of $18.90.

Crescent Capital BDC Stock Performance

Shares of Crescent Capital BDC stock opened at $16.07 on Monday. The firm has a market cap of $595.59 million, a PE ratio of 8.08 and a beta of 0.56. The firm’s 50-day simple moving average is $16.79 and its 200-day simple moving average is $18.32. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. Crescent Capital BDC, Inc. has a 1 year low of $13.54 and a 1 year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The business had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Equities analysts forecast that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC’s payout ratio is 84.42%.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.